NSETrading Window30 Sept 2026 · 30 Sept 2026, 04:25 pm

Trading Window

Vineet Laboratories Limited · VINEETLAB

✦ AI Summary

Vineet Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern5/10
Regulatory Risk5/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Vineet Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

VINEETLAB_30092026162504_Upload.pdf

pdf

Download →
View document text
September 29, 2026 To To BSE Limited, National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Mumbai- 400 001. Bandra (E), Mumbai – 400 051. BSE Scrip Code: 543298 NSE Scrip Code: VINEETLAB Dear Sir/ Madam, Subject: - Intimation of closure of Trading Window for Second Quarter ending on September 30, 2026. This is to inform that pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 read with the Company's Code of Conduct for regulating, monitoring, and reporting trading by Insiders and Code of Practices and Procedures for fair disclosure of Unpublished Price Sensitive Information, the Trading Window for dealing in the securities of the Company will remain closed from 01st October, 2026 till 48 hours after the announcement of Standalone Un-audited Financial results for the Second Quarter and Half year ending on 30th September, 2026 for all designated persons, their immediate relatives and all the connected persons covered under the said Code. Further, pursuant to SEBI Circular SEBI/HO/ISD/ISD-PoD-2/P/CIR/2023/124 dated July 19, 2023, the Company has ensured freezing the PAN of all the Designated Persons (“DPs”) and their immediate relatives during the period of trading window closure. The date of Board Meeting for declaration of the Standalone Un-Audited Financial results for the Second Quarter ending on 30th September, 2026 will be intimated in due course. Kindly take the same on your records. Thanking you. Yours faithfully, For Vineet Laboratories Limited Rajesh Kumar Kathulla Director 05349717